Transcript map of the 3.7-Mb D19S112-D19S246 candidate tumor suppressor region on the long arm of chromosome 19.

Allelic losses of the q13.3 region of chromosome 19 have been documented in malignant gliomas, neuroblastomas, and ovarian carcinomas, strongly suggesting the presence of a 19q13.3 tumor suppressor gene. Deletion mapping in tumors over the past decade has narrowed the candidate region considerably but has produced partially conflicting results, with some small candidate regions defined only by isolated tumors with deletions. Mutation and expression screening of genes from the most likely candidate regions has failed to identify the gene of interest, perhaps because of the conflicting deletion mapping data. The recently increased public availability of human genomic sequence, combined with improved bioinformatics capabilities, has now made it possible to map much larger candidate regions in considerable detail. We have manually generated a transcript map that spans most of the 19q13.3 tumor suppressor candidate region, from D19S219 to D19S246, with a resolution and quality superior to that of computer-generated maps. These results are presented in the hope that an improved map of the candidate region will facilitate further widespread screening and eventual identification of the gene or genes deleted in human gliomas, neuroblastomas, and ovarian cancers.

[1]  P. Devilee,et al.  Ever since Knudson. , 2001, Trends in genetics : TIG.

[2]  A. Godzik,et al.  TUCAN, an Antiapoptotic Caspase-associated Recruitment Domain Family Protein Overexpressed in Cancer* , 2001, The Journal of Biological Chemistry.

[3]  W. Gerald,et al.  Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  R A Betensky,et al.  Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  K. Kinzler,et al.  PUMA induces the rapid apoptosis of colorectal cancer cells. , 2001, Molecular cell.

[6]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[7]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[8]  R. Ivell,et al.  Novel sperm‐binding proteins of epididymal origin contain four fibronectin type II‐modules , 2001, Molecular reproduction and development.

[9]  K. Arden,et al.  p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas. , 2000, Gene.

[10]  S. Dowler,et al.  Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. , 2000, The Biochemical journal.

[11]  E Soeda,et al.  Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines. , 2000, Biochemical and biophysical research communications.

[12]  B. Scheithauer,et al.  Mapping of the chromosome 19 q‐arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers , 2000, Genes, chromosomes & cancer.

[13]  Sang-Hyeon Lee,et al.  Three-amino acid Extension Loop Homeodomain Proteins Meis2 and TGIF Differentially Regulate Transcription* , 2000, The Journal of Biological Chemistry.

[14]  D. Kufe,et al.  Proteolytic Cleavage and Activation of Protein Kinase C μ by Caspase-3 in the Apoptotic Response of Cells to 1-β-d-Arabinofuranosylcytosine and Other Genotoxic Agents* , 2000, The Journal of Biological Chemistry.

[15]  Y. Yonekawa,et al.  Loss of Heterozygosity on Chromosome 19 in Secondary Glioblastomas , 2000, Journal of neuropathology and experimental neurology.

[16]  P. Phillips,et al.  A novel kinase, AATYK induces and promotes neuronal differentiation in a human neuroblastoma (SH-SY5Y) cell line. , 2000, Brain research. Molecular brain research.

[17]  D. Louis,et al.  A transcript map of the chromosome 19q-arm glioma tumor suppressor region. , 2000, Genomics.

[18]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  D. Louis,et al.  EHD2, EHD3, and EHD4 encode novel members of a highly conserved family of EH domain-containing proteins. , 2000, Genomics.

[20]  C. Verlinde,et al.  Five Members of a Novel Ca2+-binding Protein (CABP) Subfamily with Similarity to Calmodulin* , 2000, The Journal of Biological Chemistry.

[21]  B. Roizman,et al.  A Novel Cellular Protein, p60, Interacting with both Herpes Simplex Virus 1 Regulatory Proteins ICP22 and ICP0 Is Modified in a Cell-Type-Specific Manner and Is Recruited to the Nucleus after Infection , 1999, Journal of Virology.

[22]  D. Louis,et al.  Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. , 1998, Journal of the National Cancer Institute.

[23]  Unnur Thorsteinsdottir,et al.  Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b , 1998, The EMBO journal.

[24]  C. Serra-Pages,et al.  Liprins, a Family of LAR Transmembrane Protein-tyrosine Phosphatase-interacting Proteins* , 1998, The Journal of Biological Chemistry.

[25]  E. Reddy,et al.  AATYK: A novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells , 1997, Oncogene.

[26]  K. Ault,et al.  Loss of heterozygosity in human ovarian cancer on chromosome 19q. , 1997, Gynecologic oncology.

[27]  H. Maruta,et al.  The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120,000 Ras GAP, independently function as anti-Ras tumor suppressors. , 1997, Cancer research.

[28]  David N. Louis,et al.  ANOVA, a putative astrocytic RNA-binding protein gene that maps to chromosome 19q13.3 , 1997, Neurogenetics.

[29]  T G Wolfsberg,et al.  A comparison of expressed sequence tags (ESTs) to human genomic sequences. , 1997, Nucleic acids research.

[30]  D. Louis,et al.  Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. , 1996, Oncogene.

[31]  E. Mardis,et al.  Generation and analysis of 280,000 human expressed sequence tags. , 1996, Genome research.

[32]  D. Louis,et al.  The BAX gene maps to the glioma candidate region at 19q13.3, but is not altered in human gliomas. , 1996, Cancer genetics and cytogenetics.

[33]  K. Huebner,et al.  Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice , 1995, Molecular and cellular biology.

[34]  D. Louis,et al.  Cloning of a highly conserved human protein serine-threonine phosphatase gene from the glioma candidate region on chromosome 19q13.3. , 1995, Genomics.

[35]  D. Louis,et al.  Chromosome 19q Deletions in Human Gliomas Overlap Telomeric to D19S219 and May Target a 425 kb Region Centromeric to D19S112 , 1995, Journal of neuropathology and experimental neurology.

[36]  B. Neyns,et al.  Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer. , 1995, Oncogene.

[37]  J. Rey,et al.  Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors , 1995, International journal of cancer.

[38]  D. Louis,et al.  Shared Allelic Losses on Chromosomes 1p and 19q Suggest a Common Origin of Oligodendroglioma and Oligoastrocytoma , 1995, Journal of neuropathology and experimental neurology.

[39]  G. Reifenberger,et al.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. , 1994, The American journal of pathology.

[40]  D. Louis,et al.  The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC. , 1994, Cancer research.

[41]  D. Lenartz,et al.  Deletion mapping of chromosome 19 in human gliomas , 1994, International journal of cancer.

[42]  R. Wellenreuther,et al.  Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. , 1994, Cancer research.

[43]  Y. Qian,et al.  A retinoblastoma-binding protein related to a negative regulator of Ras in yeast , 1993, Nature.

[44]  J. Haines,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.

[45]  B. Scheithauer,et al.  Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas , 1992, Genes, chromosomes & cancer.

[46]  I. Petersen,et al.  Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas. , 1992, Cancer research.

[47]  R. Weinberg,et al.  Molecular cloning of cDNAs encoding the GAP-associated protein p190: Implications for a signaling pathway from ras to the nucleus , 1992, Cell.

[48]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[49]  T. Seufferlein,et al.  Molecular Cloning and Characterization of the Human Protein Kinase D2 A NOVEL MEMBER OF THE PROTEIN KINASE D FAMILY OF SERINE THREONINE KINASES* , 2001 .

[50]  Seamus J. Martin,et al.  Bouchier-Hayes, L. et al. CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-B activation pathways. J. Biol. Chem. 276, 44069-44077 , 2001 .